• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX

AMPLIA THERAPEUTICS LIMITED

15.8% ! 6.6¢
Market Cap $25.60M  !

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX 11:25 15 2.5K
11:25 Last post  Meledath Comments Created with Sketch.  15  Views Created with Sketch.  2.5K 
ATX 14/06/25 9 3.0K
14/06/25 Last post  leveller Comments Created with Sketch.  9  Views Created with Sketch.  3.0K 
ATX 05/06/25 87 27K
05/06/25 Last post  reon1 Comments Created with Sketch.  87  Views Created with Sketch.  27K 
ATX 30/05/25 0 229
30/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  229 
ATX 30/05/25 0 203
30/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  203 
ATX 29/05/25 63 17K
29/05/25 Last post  vincenski Comments Created with Sketch.  63  Views Created with Sketch.  17K 
ATX
chart
14:12 1 443
14:12 Last post  Amit9997 Comments Created with Sketch.  1  Views Created with Sketch.  443 
ATX
Amplia pops 40% on liquidity surge as chemo combo proves successful
15/05/25 0 329
15/05/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  329 

See All Discussions arrow Created with Sketch.

Timeline

Pathological Complete Response in Pancreatic Cancer Trial
16 Jun 08:29
 
Appendix 4G - Key to Corporate Governance Disclosures
30 May 15:14
 
2025 Corporate Governance Statement
30 May 15:14
 
Preliminary Final Report and Annual Report YE 31 March 2025
30 May 15:13
 
Change in substantial holding
16 May 17:05
 
ACCENT Trial Achieves Superiority over Chemotherapy Alone
15 May 08:21
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.6¢
Change
0.009(15.8%)
Mkt cap ! $25.60M
Open High Low Value Volume
8.2¢ 8.4¢ 6.5¢ $1.028M 14.31M

Buyers (Bids)

No. Vol. Price($)
1 8730 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 713589 4
View Market Depth
Last trade - 10.55am 16/06/2025 (20 minute delay) ?
Last
6.6¢
  Change
0.009 ( 15.8 %)
Open High Low Volume
8.3¢ 8.5¢ 6.5¢ 3284746
Last updated 10.51am 16/06/2025 ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.